Normunity
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$75M
Normunity is a biotechnology company developing anti-cancer therapies that target novel tumor-specific mechanisms to engage T cells and suppress immune evasion in solid tumors.
Focus Areas
Biotechnology
T cell engager
Tumor-specific target
Solid tumors
Anti-cancer therapies
Immune suppression
Investors
